Cat. No. | Product name | CAS No. |
DC66389 |
WAY-620521
Featured
WAY-620521 is an active molecule. |
315693-33-5 |
DC66390 |
WAY-607695
Featured
WAY-607695 is an active molecule. |
380469-52-3 |
DC66391 |
Nurr1 agonist 7
Featured
Nurr1 agonist 7 (compound 110) is a Nurr1 agonist with an EC50 value of 0.12 μM. |
228707-95-7 |
DC66392 |
Nurr1 agonist 8
Featured
Nurr1 agonist 8 (compound 111) is a Nurr1 agonist with an EC50 value of 0.09 μM. |
360778-55-8 |
DC66393 |
WAY-221060
Featured
WAY-221060-A is an active molecule. |
1351406-38-6 |
DC66394 |
Anti-inflammatory agent 63
Featured
Anti-inflammatory agent 63 is an anti-inflammatory agent that shows optimal inhibitory activity (EC50 = 5.33±0.57 μM) against the production of nitric oxide (NO) induced by lipopolysaccharide (LPS) in RAW264.7 cells. |
2347694-79-3 |
DC66395 |
WAY-639872
Featured
WAY-639872 is an active molecule. |
796119-18-1 |
DC66396 |
WAY-215718
Featured
WAY-215718 is an active molecule. |
128175-06-4 |
DC66397 |
WAY-328127
Featured
WAY-328127 is an active molecule. |
912784-67-9 |
DC66398 |
WAY-616296
Featured
WAY-616296 is an active molecule. |
503065-67-6 |
DC66399 |
WAY-325811
Featured
WAY-325811 is an active molecule. |
869632-12-2 |
DC66400 |
WAY-649123
Featured
WAY-649123 is an active molecule. |
801244-46-2 |
DC66401 |
Tyrosinase-IN-17
Featured
Tyrosinase-IN-17 (Compound 5b) is a lipophilic, skin-permeable, and non-cytotoxic Tyrosinase inhibitor (pIC50=4.99). Tyrosinase-IN-17 can be used for research on melanin-related diseases, such as melanoma, melanogenesis, etc. |
2427043-61-4 |
DC66402 |
Aβ42 agonist-1
Featured
Aβ42 agonist-1 (compound 7a) is a small molecule compound that can promote Aβ42 aggregation. Aβ42 agonist-1 can interact with Aβ42 oligomers and pentamers to promote nontoxic aggregate self-assembly and rapid fibril formation. Aβ42 agonist-1 prevents Aβ42-induced cytotoxicity in HT22 hippocampal neuronal cells. |
50635-12-6 |
DC66403 |
Aurora kinase inhibitor-11
Featured
Aurora kinase inhibitor-11 (compound 25) is an inhibitor of Aurora Kinase with an IC50 of 0.14 μM. Aurora kinase inhibitor-11 has anticancer activity. |
923946-98-9 |
DC66404 |
Aβ42 agonist-2
Featured
Aβ42 agonist-2 (compound 7b) is a small molecule compound that can promote Aβ42 aggregation. Aβ42 agonist-2 can interact with Aβ42 oligomers and pentamers to promote nontoxic aggregate self-assembly and rapid fibril formation. Aβ42 agonist-2 prevents Aβ42-induced cytotoxicity in HT22 hippocampal neuronal cells. |
6314-40-5 |
DC66405 |
ATG12-ATG3 inhibitor 1
Featured
ATG12-ATG3 inhibitor 1 (compound 189) is a potent inhibitor of autophage. |
333351-38-5 |
DC66406 |
hCAI/II-IN-7
Featured
hCAI/II-IN-7 (compound 1F) is a potent carbonic anhydrase (CA) inhibitor with Ki values of 23 nM, 44 nM and 20.57 µM for hCA-I, hCA-II and bovine CA, respectively. |
14204-32-1 |
DC66407 |
HDAC6-IN-27
Featured
HDAC6-IN-27 (compound 8C) is a HDAC inhibitor with IC50 vales of 15.9 nM 136.5 nM and 6180.2 nM for HDAC6, HDAC8 and HDAC1, respectively. HDAC6-IN-27 shows potent antiparasitic effects. |
2758023-91-3 |
DC66408 |
AN-12-H5 intermediate-3
Featured
AN-12-H5 intermediate-3 is an intermediate of the viral inhibitor AN-12-H5 (HY-120900) and can be used to synthesize Antibody-Drug Conjugates (ADCs). |
851314-03-9 |
DC66409 |
Anti-osteoporosis agent-6
Featured
Anti-osteoporosis agent-6 (compound 174) is an anti-osteoporosis agent. Anti-osteoporosis agent-6 has 14.11% inhibition rate against osteoclast formation at 10 μM. |
445231-36-7 |
DC66410 |
Anti-osteoporosis agent-5
Featured
Anti-osteoporosis agent-5 (compound 189) is a potent inhibitor of the formation of osteoclasts. |
444908-22-9 |